In addition to significantly reducing blood glucose, GLP‐1R agonists can also reduce weight, blood pressure, improving the function of β cell, which showed the potential to delay the progress of diabetes and reduce cardiovascular complications.13 Here, GLP1R is linked to diabetes mellitus.